Infórmate

¿Quieres saber más sobre el mecanismo de los fármacos utilizados para tratar las crisis de pánico? Los artículos sobre farmacología publicados en este sitio utilizan las siguientes referencias bibliográficas:

Referencias:

Australian Drug Foundation [ADF] (2012). Drug Info. Benzodiazepine facts. Recuperado el 24 de junio del 2016, de http://www.druginfo.adf.org.au/drug-facts/benzodiazepines

American Psychiatric Association [APA] (2009). Practice guideline for the Treatment of Patients With Panic Disorder [2nd ed.]. Recuperado el 14 de septiembre del 2014, de http://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/panicdisorder.pdf

American Psychiatric Association [APA] (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: American Psychiatric Publishing.

Baldwin, D. et al. (2014). Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for Psychopharmacology. Journal of Psychopharmacology, 1–37.

Barker, M., Greenwood, K., Jackson, M. y Crowe, S. (2004). Cognitive effects of long-term benzodiazepine use: a meta-analysis. CNS Drugs, 18(1):37-48.

Brown, D. y Tomlin, M. (2010). Pharmacokinetic principles. En Mark Tomlin (Ed.). Pharmacology & pharmacokinetics: A basic reader. Londres: Springer-Verlag.

Cascade, E., Kalali, A. H., & Kennedy, S. H. (2009). Real-world data on SSRI antidepressant side effects. Psychiatry (Edgmont), 6(2):16-8.

Cole, J. y Kando, J. (1993). Adverse behavioral events reported in patients taking alprazolam and other benzodiazepines. The Journal of clinical psychiatry, 54: 62–3.

den Boer J. (1998). Pharmacotherapy of panic disorder: differential efficacy from a clinical viewpoint. Journal of Clinical Psychiatry, 59:30–6.

Gundersen, V.; Storm-Mathisen, J. y Bergersen, L. (2015). Neuroglial transmission. Physiological Reviews, 95(3):695- 726.

Hertzman, M. y Adler, L. (2010). Clinical Trials in Psychopharmacology: A Better Brain. UK: John Wiley & Sons, Ltd.

Laterra, J., Keep, R., Betz, L. y Goldstein, G. (1999). Bypassing the Barriers with Drugs. En George Siegel (Ed.) Basic Neurochemistry: Molecular, Cellular and Medical Aspects. [6th ed]. Philadelphia: Lippincott-Raven

Leonardo, E. y Hen, R. (2006). Genetics of affective and anxiety disorders. Annual Review of Psychology, 57:117-37.

Lichtblau, L. (2010). Psychopharmacology Demystified. New York: Delmar Cengage Learning.

Maddock, R., Buonocore, M., Copeland, L. y Richards, A. (2009). Elevated brain lactate responses to neural activation in panic disorder: a dynamic 1H-MRS study. Molecular Psychiatry, 14:537–45.

Marchesi, C. (2008). Pharmacological management of panic disorder. Neuropsychiatric Disease & Treatment, 4(1), 93–106.

Moncrieff, J., Cohen, D. & Porter, S. (2013) The psychoactive effects of psychiatric medications: the elephant in the room. Journal of Psychoactive Drugs, 45, 409-415.

Rotella, F., Marinoni, M., Lejeune, F., Alari, F., Depinesi, D., Cosci F., y Faravelli C. (2014) Brain Circulation during Panic Attack: A Transcranial Doppler Study with Clomipramine Challenge. Psychiatry Journal:296862.

Stein, D. (2008). Philosophy of Psychopharmacology: Smart Pills, Happy Pills, and pep Pills. Cambridge, UK: Cambridge University Press.